Innovent and Roche link on lung cancer therapy development

Innovent and Roche have entered a partnership and exclusive licence agreement to accelerate the development of IBI3009.

Jan 2, 2025 - 06:00

Innovent and Roche link on lung cancer therapy development

Innovent and Roche have entered a partnership and exclusive licence agreement to accelerate the development of IBI3009.

Read the original article

Tags:

Previous Article

New Insights Uncover Why Lungs are Common Targets for Cancer Metastasis

Sangamo’s stock sinks 50% as Pfizer halts haemophilia A gene therapy partnership

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Amgen in artificial intelligence: theme innovation stra...

Mar 5, 2024

STAT+: AbbVie purchases neuroscience developer Cerevel for $8.7 billion

STAT+: AbbVie purchases neuroscience developer Cerevel ...

Dec 7, 2023

Gilead acquires CymaBay Therapeutics for $4.3bn

Gilead acquires CymaBay Therapeutics for $4.3bn

Mar 26, 2024